How to cite item

DARPP-32 and t-DARPP isoform in non-small cell lung cancer (NSCLC): could they drive patients’ clinical management and be a therapeutic target?

   
@article{TLCR26143,
	author = {Giuseppe Lamberti and Chiara Peterle and Francesco Gelsomino},
	title = {DARPP-32 and t-DARPP isoform in non-small cell lung cancer (NSCLC): could they drive patients’ clinical management and be a therapeutic target?},
	journal = {Translational Lung Cancer Research},
	volume = {7},
	number = {Suppl 4},
	year = {2018},
	keywords = {},
	abstract = {Lung cancer remains the main cause of cancer-related death worldwide (1). In the last decade, the most significant improvements in non-small cell lung cancer (NSCLC) have been made through identification and exploiting of novel therapeutic targets. Among them, sensitizing EGFR mutations, ALK and ROS-1 gene rearrangements are the main targetable alterations that have deeply changed both clinical management and outcomes of these patients. Furthermore, the new antibody agents directed against programmed death 1 (PD-1) protein or its ligand (PD-L1) have recently opened the way to a new paradigm shift in the treatment strategies of different solid tumors, including lung cancer.},
	issn = {2226-4477},	url = {https://tlcr.amegroups.org/article/view/26143}
}